MoonLake Immunotherapeutics MLTX Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from MoonLake Immunotherapeutics’s reported figures.
Based on trailing twelve months.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's earnings yield?
- MoonLake Immunotherapeutics (MLTX) reported earnings yield of -19.2% in Q1 2026.
- How has MoonLake Immunotherapeutics's earnings yield changed year-over-year?
- MoonLake Immunotherapeutics's earnings yield decreased by 227.4% year-over-year, from -5.9% to -19.2%.
- What is the long-term trend for MoonLake Immunotherapeutics's earnings yield?
- Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's earnings yield has grown at a -1.0% compound annual growth rate (CAGR), from -25.4% to -24.3%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.